Ignite Creation Date:
2024-05-06 @ 8:21 PM
Last Modification Date:
2024-10-26 @ 3:25 PM
Study NCT ID:
NCT06344767
Status:
COMPLETED
Last Update Posted:
2024-04-03
First Post:
2024-03-28
Brief Title:
Positive ER Expression Assessed by 18F-FES PETCT in the MBC with ER-negative Primary Tumor
Sponsor:
Fudan University
Organization:
Fudan University
Study Overview
Official Title:
Positive Estrogen Receptor ER Expression Assessed by 18F-fluoroestradiol Positron Emission TomographyComputed Tomography 18F-FES PETCT in the Metastatic Breast Cancer MBC with ER- Negative Primary Tumor
Status:
COMPLETED
Status Verified Date:
2024-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
To investigate the treatment pattern and efficacy of patients with negative primary ER lesion but positive ER expression in MBC using a novel convenient way of 18F-fluoroestradiol positron emission tomographycomputed tomography 18F-FES PETCT
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None